GlobeNewswire 10-21 Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt...
GlobeNewswire 10-21 AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene ...
GlobeNewswire 10-21 New TransUnion Research Reveals Marketers’ Confidence in Measurement Has Stalled
GlobeNewswire 10-20 Invest in Bogotá Strengthens the City’s Regional Leadership in the Shared Services Industry
GlobeNewswire 10-20 ST introduces new image sensors for industrial automation, security and retail applications
GlobeNewswire 10-17 Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Adjuvant Treatment of Cutaneous Sq...
GlobeNewswire 10-16 Building a Resilient Agrifood System: 2025 World Agrifood Innovation Conference Opens in Beijing
GlobeNewswire 10-16 AdvanCell appoints experienced biotech and pharma leader, Andrew Kay, as Chair of the Board of Direc...
GlobeNewswire 10-15 Regeneron Showcases Advances Across Oncology Portfolio and Pipeline at ESMO, Highlighting Novel and ...
GlobeNewswire 10-14 Dewpoint Therapeutics Announces Presentation at AACR-NCI-EORTC 2025
GlobeNewswire 10-12 DB-OTO Results in the New England Journal of Medicine Showcase Dramatic and Sustained Improvements i...
GlobeNewswire 10-10 AskBio Presents Interim Safety Results from Phase 1/Phase 2 LION-CS101 Clinical Trial of AB-1003 in ...
GlobeNewswire 10-08 Libtayo® (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatme...
GlobeNewswire 10-06 Daré Bioscience Receives $4 Million Non-Dilutive Grant Installment; Total of $41.8M Received to Date...
TeleTrader 10-06 Europe opens mostly lower ahead of data
GlobeNewswire 10-03 Luke Bryan and Bayer discuss the Take Care, Now campaign With YourUpdateTV
GlobeNewswire 10-02 AskBio Announces 6 Presentations at the European Society of Gene and Cell Therapy 32nd Annual Meetin...
GlobeNewswire 09-30 Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kama...
GlobeNewswire 09-26 Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old...
GlobeNewswire 09-25 BotCity Secures $12 Million Series A Funding to Address Growing Risks in “Shadow Automation”
GlobeNewswire 09-24 Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
GlobeNewswire 09-24 BIO-Europe® 2025: Vienna Prepares to Welcome Global Biopharma Leaders
GlobeNewswire 09-22 First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson...
GlobeNewswire 09-22 First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational c...
GlobeNewswire 09-22 Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU...